MARCHESE, ANNA
 Distribuzione geografica
Continente #
EU - Europa 31.223
Totale 31.223
Nazione #
IT - Italia 31.223
Totale 31.223
Città #
Genova 23.538
Rapallo 4.251
Genoa 3.121
Vado Ligure 220
Bordighera 93
Totale 31.223
Nome #
Confronto tra gli effeti dei mucolitici N-acetilcisteina, ambroxol, bromexina e sobrerolo sulla sintesi e sulla degradazione di biofilm di Staphylococcus aureus. 1.622
Potentially human pathogenic vibrios in marine and fresh bathing waters related to environmental conditions and disease outcome 242
Emergence of a KPC-3-Producing Escherichia coli ST69 as a Cause of Bloodstream Infections in Italy 178
Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients 146
Epidemiological study of pathogens isolated from blood in Liguria during 2011. 144
Efficacy of N-acetyl-cysteine in combination with thiamphenicol in sequential (intramuscular/aerosol) therapy of upper respiratory tract infections even when sustained by bacterial biofilms 141
Antibiotic susceptibility patterns and serotypes of antibiotic resistant and or invasive Streptococcus pneumoniae strains circulating in Italy 139
. Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe. 135
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery 132
DNA bacterial load in children with bacteremic pneumococcal community-acquired pneumonia. 132
The Susceptibility of Candida albicans to Gamma-Radiations and Ketoco-nazole Depends on Transitional Filamentation. 132
Analysis of clinical management of infected breast implants and of factors associated to successful breast pocket salvage in infections occurring after breast reconstruction 130
Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study 129
Active surveillance of Streptococcus pneumoniae bacteremia in Italian children 125
Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp. 124
The role of macrolides in Streptococcus pyogenes pharyngitis. 124
Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy. 123
Bordetella holmesii endocarditis in a patient with systemic lupus erythematous treated with immunosuppressive agents. 123
In vitro activity of quinupristin/dalfopristin against selected bacterial pathogens isolated in Italy 122
Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis 122
Emergence of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains and spread of an isolate of sequence type 258 in the neuro-rehabilitation unit of an Italian hospital. 122
A Fatal Case of Nosocomial Legionnaires' Disease: Implications From an Extensive Environmental Investigation and Isolation of the Bacterium From Blood Culture. 122
Antistaphylococcal activity of cefdinir, a new oral third-generation cephalosporin, alone and in combination with other antibiotics, at supra- and sub-MIC levels. 121
Resistance patterns of lower respiratory tract pathogens in Europe. 119
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 119
Antibacterial activity of polyphenols. 119
Predictive Models for Identification of Hospitalized Patients Harboring KPC-Producing Klebsiella pneumoniae. 118
European survey of glycopeptide susceptibility: Staphylococcus spp. 118
Early carbapenem-resistant Klebsiella pneumoniae bacteraemia: should we expand the screening? 117
Post antibiotic effect and delay of regrowth in strains carrying mutations that save proteins or RNA 117
Clinical and Microbiological Characterization of Late Breast Implant Infections after Reconstructive Breast Cancer Surgery 117
Activity of Bay 12-8039 against well-characterised antibiotic resistant S.pyogenes. 115
Bacterial isolates from severe infections and their antibiotic susceptibility patterns in Italy: a nationwide study in the hospital setting 114
Detection of macrolide resistance genes in Streptococcus pneumoniae using a rapid method 113
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis 113
Influence of in vitro simulated gastroduodenal digestion on the antibacterial activity, metabolic profiling and polyphenols content of green tea (Camellia sinensis). 113
The oxazolidinones as a new family of antimicrobial agent. 112
Epidemiology of multi-resistance Gram negative pathogen circulating in Liguria and molecular characterization of different carbapenemases. 112
In vitro antimicrobial activity of tigecycline against Gram-negative and Gram-positive pathogens collected in Northen Italy (T.E.S.T. program 2010). 112
Plasmid loss from gram-negative bacteria exposed to subinhibitory concentrations of beta-lactam drugs and azithromycin. 111
Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations 111
Attività antibatterica di N-acetilcisteina sui principali patogeni responsabili di infezioni delle alte vie respiratorie e sui germi del cavo orale. 111
Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe. 110
. In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance 110
Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy 110
Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: should we get to the PK/PD root of the paradox? 110
Antibiotic susceptibility tests directly on urine samples using Uro-Quick, a rapid automated system 109
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 109
Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa. 108
Adesione batterica e fungina a materiali protesici del cavo orale. 107
Breast implant infection due to Paenibacillus residui in a cancer patient 107
Antibiotic susceptibility and serotype distribution in Streptococcus pneumoniae circulating in Italy: results of the SEMPRE surveillance study (2000-2002). 107
Antimicrobial susceptibility profiles of Pseudomonas aeruginosa and Staphylococcus aureus isolated in Italy from patients with hospital-acquired infections. 106
The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections 105
European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. 105
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 105
In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance 105
Pleiotropic effect of sodium arsenite on Escherichia coli 104
Antibiotic susceptibility patterns and serotypes of nasopharyngeal Streptococcus pneumoniae circulating in healthy italian children. 103
In vitro activity of quinupristin/dalfopristin against selected bacterial pathogens isolated in Italy 102
Microbial epidemiology patterns of surgical infection pathogens. 102
Antibiotic resistance among S.pneumoniae isolated in Italy. 102
Antibiotic persistence: the role of spontaneous DNA repair response 102
In vitro interaction between ceftazidime and vancomycin/teicoplanin in the presence of azithromycin against Pseudomonas aeruginosa. 101
Evolution of antibiotic resistance in Gram-positive pathogens 100
Enhanced biofilm-production in pathogens isolated from patients with rare metabolic disorders 100
Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults 100
Activity of Teicoplanin, Vancomycin and 8 Other Drugs Against Gram-Positive Pathogens Isolated in Italy 100
Alteration of Membrane Permeability of Bacteria and Yeast by High Frequency Alternating Current (HFAC). 100
Susceptibility of Streptococcus pneumoniae strains isolated in Italy to penicillin and ten other antibiotics. 100
Antimicrobial activity of eugenol and essential oils containing eugenol: A mechanistic viewpoint 100
In vitro activity of ceftibuten at sub-inhibitory concentrations in comparison with other antibiotics against respiratory and urinary tract pathogens 99
Phenotypic and genotypic characterization of Staphylococci causing breast peri-implant infections in oncologic patients. 97
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from multicenter case-control-control-study. 97
Phytochemicals for human disease: An update on plant-derived compounds antibacterial activity 97
Recent findings from multinational resistance surveys: are we 'PROTEKTed' from resistance? 97
Identificazione di resistenze agli antibiotici ben caratterizzate mediante sistema Uro-Quick. 96
Clinical microbiology of oral cephalosporins 96
Comparative in vitro potency of gemifloxacin against European respiratory tract pathogens isolated in the Alexander Project 96
Epidemiology of serious nosocomial infections: recent data from the Spin survey. 95
Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak 95
Characterization of Fluoroquinolone-Resistant Escherichia coli Causing Septicemic Colibacillosis in Calves in Italy: Emergence of a Multiresistant O78 Clonal Group. 95
Identification of a New Delhi metallo-β-lactamase-4 (NDM-4)-producing Escherichia coli in Italy. 95
Evaluation of induced and spontaneous contamination of ocular medications after first opening. 94
Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms. 94
Molecular characterization of hospital-acquired methicillin-resistant Staphylococcus aureus strains in pediatric outbreaks using variable tandem repeat analysis with spa and ClfB typing. 93
Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital 91
Indagine sulla diffusione di stafilococchi resistenti alla meticillina in Liguria 91
La concentrazione che previene lo sviluppo di mutanti resistenti (MPC): un nuovo parametro per la scelta tra Fluorochinoloni 91
Plants belonging to the genus Thymus as antibacterial agents: from farm to pharmacy. 91
Comparative activity of linezolid against staphylococci and enterococci isolated in Italy 90
Evoluzione di Streptococcus agalactiae verso la resistenza alla penicillina 90
Characterization of FOX-3, an AmpC-type plasmid-mediated beta-lactamase from an Italian isolate of Klebsiella oxytoca. 90
In vitro activity of ABT773, a new ketolide derivative exhibiting innovative microbiological properties against well-characterised antibiotic resistant pathogens in Italy. 90
Evaluation of the post-antibiotic effect induced by various antibiotics against staphylococci and enterococci. 89
Evaluation of the Uro-Quick, a new rapid automated system, for the detection of well-characterized antibiotic-resistant bacteria 89
Predictors of Mortality in Bloodstream Infections Caused by KPC-Producing Klebsiella pneumoniae: Importance of Combination Therapy. 89
Antibiotic persistence: the role of spontaneous DNA repair. 88
The beta-lactamase problem: new therapeutic options. 88
Antigenic and anticorpal diagnosis of invasive aspergillosis and candidosis in immunocompromised host. 88
Totale 12.531
Categoria #
all - tutte 81.963
article - articoli 53.859
book - libri 0
conference - conferenze 27.984
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 120
Totale 163.926


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.519 0 187 535 360 752 820 1.459 387 685 1.739 1.083 512
2020/20211.899 91 125 134 220 131 204 92 136 303 177 165 121
2021/20224.798 101 376 209 603 278 264 426 1.144 158 449 139 651
2022/20235.140 535 275 125 473 787 972 47 450 897 79 429 71
2023/20242.308 132 353 72 211 188 459 121 152 119 62 112 327
2024/2025266 188 78 0 0 0 0 0 0 0 0 0 0
Totale 31.427